Results 171 to 180 of about 165,796 (318)

Atherogenic Index of Plasma (AIP) as a Long‐Term Prognostic Factor Following CABG: Unveiling Insights From a Large‐Scale Tertiary Center Registry Analysis

Health Science Reports, Volume 8, Issue 4, April 2025.
ABSTRACT Background and Aims The role of the atherogenic index of plasma (AIP) in predicting major adverse cerebro‐cardiovascular events (MACCE) after coronary artery bypass grafting (CABG) surgery has not been fully explored. The present study aims to investigate the prognostic value of AIP in predicting MACCE and its individual components following ...
Abolfazl Salari, Parvin Kalhor, Ahmad Vakili‐Basir, Houshang Bavandpour Karvane, Mina Pashang, Mojgan Ghavami, Arash Jalali, Farshid Alaeddini, Farzad Masoudkabir   +8 more
wiley   +1 more source

Acute coronary artery occlusion during percutaneous transluminal coronary angioplasty: reopening by intracoronary streptokinase before emergency coronary artery surgery to prevent myocardial infarction. [PDF]

, 1982
Joachim Schofer, H.-J. Krebber, W. Bleifeld, Detlef G. Mathey   +3 more
openalex   +1 more source

Combined Treatment With Lipoprotein Apheresis and Hemodialysis in Patients With Severe Cardiovascular Disease, High Lipoprotein(a) and End Stage Renal Disease

Journal of Clinical Apheresis, Volume 40, Issue 2, April 2025.
ABSTRACT Elevated Lipoprotein(a) (Lp(a)) is a known independent cardiovascular risk factor. Lp(a) Lipoprotein Apheresis (LA) substantially reduces the number of cardiovascular events. The effect of LA treatment in hemodialysis (HD) patients remains unknown. Retrospective analysis of nine patients undergoing LA and HD.
Tilmann Röseler, Daniel Kayser, Georg Schlieper, Wanja M. Bernhardt   +3 more
wiley   +1 more source

Adventitial cystic disease of the popliteal artery: Failure of percutaneous transluminal angioplasty as a therapeutic modality [PDF]

, 1985
R. L. Fox, Mark Kahn, John R. Adler, Barry Sussman, Donna Mendes, Ibrahim M. Ibrahim, Herbert Dardik   +6 more
openalex   +1 more source

Balloon Angioplasty

Journal of Interventional Cardiology, 2001
Thach Nguyen, THACH NGUYEN, PHAM MANH HUNG, NGUYEN QUANG TUAN, JAMES HERMILLER, JOHN S. DOUGLAS, CINDY GRINES   +6 more
openaire   +2 more sources

Anxiety and Depression in Patients Undergoing Coronary Angioplasty

Journal of Client-centered Nursing Care, 2016
Background: Anxiety and depression are the most important factors on the quality of life in patients after coronary angioplasty. These patients have less capability for adjusting themselves with changes in life style, diet, medication and physical ...
Leila Rouhi Balasi, Arsalan Salari, Azam Nourisaeed, Fatemeh Moaddab, Maryam Shakiba, Hamed Givzadeh   +5 more
doaj  

Pulmonary Artery Stent Implantation for Fibrosing Mediastinitis: Our Clinical Experience

Pulmonary Circulation, Volume 15, Issue 2, April 2025.
ABSTRACT Fibrosing mediastinitis (FM) can block pulmonary vessels and airways, hindering treatment efficacy. Pulmonary artery (PA) stenting might provide a solution in such cases. This study involved 30 patients who had 49 PA stenting procedures for FM.
Cheng Hong, Daibing Zhou, Haiming Chen, Xiaofeng Wu, Wenliang Guo, Jiangyu Cui, Weijie Guan, Nanshan Zhong, Jielong Lin   +8 more
wiley   +1 more source

Successful management of iliac artery perforation during peripheral angioplasty: a case report. [PDF]

Eur Heart J Case Rep
Sahoo SK, Panda D, Acharya D, Barik R, Pramanik S.   +4 more
europepmc   +1 more source

Balloon valvuloplasty and angioplasty in congenital heart disease. [PDF]

, 1985
Graham Miller
openalex   +1 more source

Long‐Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH Study Open Label Extension)

Pulmonary Circulation, Volume 15, Issue 2, April 2025.
ABSTRACT The aim of the open label extension (OLE) of CTREPH study was to characterize multimodal treatment in patients with severe inoperable CTEPH, to describe long‐term subcutaneous (SC) treprostinil safety and tolerability, and to evaluate change in functional class and exercise capacity over 24 months since completion of the blinded phase of ...
Pavel Jansa, Roela Sadushi‐Kolici, Nika Skoro‐Sajer, Grzegorz Kopec, Iveta Simkova, Regina Steringer‐Mascherbauer, Barbara Salobir, Jaroslav Lindner, Irene M. Lang   +8 more
wiley   +1 more source